Is rivaroxaban associated with higher morbidity and mortality in patients with traumatic head injuries? A retrospective cohort study comparing rivaroxaban, no anticoagulation, and phenprocoumon

•Potential association of new anticoagulants with morbidity or intracranial bleeding.•Retrospective cohort study (3 groups: rivaroxaban, no anticoagulant, phenprocoumon).•No significant differences in morbidity or intracranial bleeding (n = 69).•One patient died likely due to head trauma in rivaroxa...

Ausführliche Beschreibung